Ohr Pharmaceutical Announces $2.9 Million Financing
News | 01 July 2012
Contact: Investor Relations: Tel: (877) 215-4813 Email:
Click on the link to read the full article at Healthcare Global (press release)
(This link will open in a new window)
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
